SHILPAMED evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-10-01T14:00:34.428083+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 15388700000.0
- net_income
- 2433300000.0
- operating_cash_flow
- 2952300000.0
- free_cash_flow
- -754000000.0
- total_assets
- 37056100000.0
- total_liabilities
- 11144100000.0
- total_equity
- 25912000000.0
- cash
- 412600000.0
- total_debt
- 6598600000.0
- revenue_growth
- 0.1962477712270101
- earnings_growth
- 2.1079406843523687
- net_margin
- 0.15812251847134587
- roe
- 0.0939062982401976
- debt_to_equity
- 0.25465421426366164
- cash_conversion
- 1.2132905930218223
- free_cash_flow_margin
- -0.04899699129881017
- trailing_pe
- 53.34
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-efd0bea00708076924a1ffeab29dbcb625d5a46e2480a477934fdab36ee63266
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 6f7efc6c64c4047d1d44959516a153af90a5df6a9a2690e5a217c2a62a6b9922
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 532794df01057e53e72e11302bf0e973ca238a174b84aa3b297b7a1720bdcd2e
- daily-price: 3b9107f111aa07b997de0e80613e45f707ebdcec7cd50008ba313c2bd50c6e70
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: VERIFIED.
- The cached closing price on 2026-10-01 was INR 1064.10.
- The trailing 5-session price return was 4.22%.
- The trailing 20-session price return was 14.49%.
- The trailing 60-session price return was 76.89%.
- The trailing 250-session price return was 167.93%.
- Average cached traded value over twenty sessions was INR 966,818,906.
- The closing price was -0.37% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-10-01T14:00:34.428083+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.1962477712270101.
- The cached financial metric net margin is 0.15812251847134587.
- The cached financial metric roe is 0.0939062982401976.
- The cached financial metric debt to equity is 0.25465421426366164.
- The cached financial metric cash conversion is 1.2132905930218223.
- The cached financial metric free cash flow margin is -0.04899699129881017.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.